Copyright
©The Author(s) 2025.
World J Diabetes. Jun 15, 2025; 16(6): 106720
Published online Jun 15, 2025. doi: 10.4239/wjd.v16.i6.106720
Published online Jun 15, 2025. doi: 10.4239/wjd.v16.i6.106720
Table 3 The role of iron metabolism dysregulation in diabetic osteoporosis
Mechanism type | Key factors | Pathway | Impact on bone metabolism | Ref. |
Iron overload | Iron ions (Fe2+/Fe3+) | Excess iron generates ROS via the Fenton reaction, causing oxidative stress and lipid peroxidation | Damages osteoblasts, inhibits their differentiation and function, reduces bone formation; promotes osteoclast differentiation, increasing bone resorption | Zang et al[59], Liu et al[62], Harrison et al[65] |
Ferroptosis (iron-dependent cell death) | GPX4, SLC7A11, ROS | Iron-dependent cell death involving lipid peroxidation and antioxidant system imbalance | Induces bone cell death, disrupts bone tissue structure, and promotes the progression of osteoporosis | Yang et al[68] |
Hepcidin dysregulation | Hepcidin, FPN1 | Overexpression of hepcidin inhibits iron export protein FPN1, leading to intracellular iron accumulation | Increases iron content in bone marrow mesenchymal stem cells, inhibits their differentiation into osteoblasts, reduces bone formation | Zang et al[59] |
Hyperglycemia-induced dysregulation | Hyperglycemia, AGEs, ROS | High-glucose environment promotes AGEs formation; AGEs bind to their receptors, inducing ROS production and iron metabolism dysregulation | Causes osteoblast dysfunction, enhances osteoclast activity, and exacerbates osteoporosis | Xie et al[71], Dludla et al[72], Zhao et al[73] |
- Citation: Wang YB, Li ZP, Wang P, Wang RB, Ruan YH, Shi Z, Li HY, Sun JK, Mi Y, Li CJ, Zheng PY, Zhang CJ. Iron dysregulation, ferroptosis, and oxidative stress in diabetic osteoporosis: Mechanisms, bone metabolism disruption, and therapeutic strategies. World J Diabetes 2025; 16(6): 106720
- URL: https://www.wjgnet.com/1948-9358/full/v16/i6/106720.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i6.106720